baber/WOPTO huggingface dataset:
Patent NZ-250400-A (NZ)
Title: Recovery of alpha-lactalbumin and beta-lactoglobulin from whey protein product
Inventor: DE WIT JACOBUS NICOLAAS
IPC: A23J3/08
Filed: 1993-12-09
Abstract: This invention relates to a process for the recovery of  alpha -lactalbumin and/or  beta -lactoglobulin enriched whey protein concentrate from a whey protein product. The process comprises the following steps:   a) incubating a solution comprising said whey protein product with a calcium-binding ionic exchange resin in its acid form to initiate the instabilization of  alpha -lactalbumin, b) adjusting the pH of the treated protein product solution to a value between 4.3 and 4.8, after separation of said resin, c) incubating said protein product solution at a temperature between 10 and 50 DEG C to promote the flocculation of  alpha -lactalbumin, d) fractionating the proteins in said protein product solution at pH 4.3-4.8, providing an  alpha -lactalbumin enriched fraction and a beta -lactoglobulin enriched fraction, e) raising the pH of the  alpha -lactalbumin enriched fraction sufficiently to solubilize the  alpha -lactalbumin fraction, and f) optionally raising the pH of the  beta -lactoglobulin enriched fraction sufficiently to neutralize the  beta -lactoglobulin fraction.
Patent NZ-257138-A (NZ)
Title: Multi-use piston emptied drum with disposable disc-shaped insert
Inventor: GRAB HANS
IPC: B65D57/00
Filed: 1993-10-28
Abstract: PCT No. PCT/EP93/02992 Sec. 371 Date Nov. 2, 1995 Sec. 102(e) Date Nov. 2, 1995 PCT Filed Oct. 28, 1993 PCT Pub. No. WO94/11271 PCT Pub. Date May 26, 1994A container for storing adhesive and sealant materials comprising (a) a container having a closed bottom end and an open top end, (b) an insert in the form of a disk interposed between the closed bottom end of the container and the adhesive and sealant materials contained in the container, the disk having a diameter slightly smaller than that of the container, and (c) a sheath superimposed over one face of the disk to provide overlapping perimeter edges which are folded onto an exposed face of the disk.
Patent NZ-273816-A (NZ)
Title: Progesterone-containing delivery device comprising crosslinked polycarboxylic acid polymer
Inventor: BOLOGNA WILLIAM JOSEPH
IPC: A61P5/24
Filed: 1994-09-13
Abstract: The invention relates to the use of a cross-linked polycarboxylic polymer and progesterone for the manufacture of a medicament for the treatment or prevention of a clinical disorder treatable by progesterone in a female patient, wherein said medicament is formulated for vaginal administration and in a form suitable to maintain a serum level of progesterone of from 1.0 to 6.0 ng/mL. Also provided is the use of a cross-linked polycarboxylic polymer and progesterone for the manufacture of a medicament wherein said medicament is formulated for vaginal administration and in a form suitable to cause secretory transformation of the endometrium and maintain serum levels of progesterone between 1.0 ng/mL and 6.0 ng/mL for a continuous period of at least forty-eight hours.
Patent NZ-312329-A (NZ)
Title: Cryopreservation and recovery of plant cells
Inventor: KADKADE PRAKASH G
IPC: A01N1/02
Filed: 1996-06-07
Abstract: The present invention relates to methods for cryopreserving plant cells and to methods for recovering viable plant cells from long or short term cryopreservation. Plant cells to be cryopreserved can be grown in culture and pretreated with a solution containing an cryoprotective agent and, optionally, a stabilizer. Stabilizers are preferably membrane stabilizers such as ethylene inhibitors, oxygen radical scavengers and divalent cations. Cells can also be stabilized by subjecting the culture to a heat shock. Pretreated cells are acclimated to a reduced temperature and loaded with a cryoprotective agent such as DMSO, propylene glycol or polyethylene glycol. Loaded cells are incubated with a vitrification solution which, for example, comprises a solution with a high concentration of the cryoprotective agent. Vitrified cells retain less than about 20% water content and can be frozen at cryopreservation temperatures for long periods of time without significantly altering the genotypic or phenotypic character of the cells. Plant cells may also be cryopreserved by lyophilizing cells prior to exposure to a vitrification solution. The combination of lyophilization and vitrification removes about 80% to about 95% of the plant cell's water. Cells can be successfully cryopreserved for long periods of time and viably recovered. The invention also relates to methods for the recovery of viable plant cells from cryopreservation. Cells are thawed to about room temperature and incubated in medium containing a cryoprotective agent and a stabilizer. The cryoprotective agent is removed and the cells successfully incubated and recovered in liquid or semi-solid growth medium. The invention also relates to the cryopreserved cells and to viable plant cells which have been recovered from long or short term cryopreservation.
Patent NZ-332835-A (NZ)
Title: Deacidifying hydrocarbon containing gas by contacting with solvent under temperature gradient
Inventor: LEBAS ETIENNE
IPC: B01D53/62
Filed: 1998-11-17
Abstract: A fluid such as a gas containing at least one acid gas and at least one hydrocarbon is processed to free it of acid gases.  The gas being processed is contacted with a phase which is selective towards the acid gases, such as a mixture of a polar solvent and of water.  Simultaneously, a temperature gradient is produced in the gas to prevent condensation of a liquid hydrocarbon phase and to produce a processed gas low in acid gases.  The temperature gradient is determined by the properties of the gas being processed.  The gas and acid gas selective phase are brought together in a contactor C1, where the temperature gradient is produced.  The processed gas is discharged through line 3.
Patent NZ-333781-A (NZ)
Title: Feline vaccine comprising at least three polynucleotide vaccine valencies each comprising a plasmid integrating a gene with one feline pathogen valency
Inventor: AUDONNET JEAN-CHRISTOPHE
IPC: A61P31/04
Filed: 1997-07-15
Abstract: Vaccine formula for cats comprising at least 3 polynucleotide vaccine valencies comprised within plasmids so as to express in vivo a gene with one feline pathogen valency which are: Feline leukaemia virus with genes env and gag, Panleukopenia virus with gene VP2, Infectious peritonitis virus with modified S and M, Coryza virus with gene gB and gD, Calicivirosis virus with a capsid, Feline immunodeficiency virus with genes env and gag/pro, Rabies virus with gene G. Further disclosed is a method and kit for vaccinating cats with one or more of the above plasmids where the cat has previously been vaccinated.
Patent NZ-336655-A (NZ)
Title: A method relating to telephone communications including the transmission of advertising messages
Inventor: ANDER CARL
IPC: H04M3/487
Filed: 1998-01-19
Abstract: A method relating to telecommunications is disclosed wherein a call is connected between two subscribers, wherein the call is billed to a third subscriber, wherein the telephone of a first subscriber is connected to the telephone of a second subscriber via a standard telephone network, wherein the first subscriber dials a subscriber number, preferably preceded by a prefix, that leads to the third subscriber and dials a subscriber number that leads to the second subscriber, wherein the telephone network is caused to connect the call to a telephone network connected computer unit (4) that forwards the call to said second subscriber such as to connect said first subscriber with said second subscriber, and wherein the call between the first and the second subscriber is billed to the third subscriber, wherein advertisements are transmitted on the call connected between the first and the second subscriber. The method is characterized in that when one of the first and the second subscribers enters a code or the like through the keypad of the telephone concerned during an ongoing call, the computer unit (4) is caused to sense said code; in that when sensing the code, the computer unit is caused to interrupt transmission of advertisements during the course of the call; and in that the computer unit is caused to bill the remainder of the connected call in accordance with fixed telephone charges.
Patent NZ-337233-A (NZ)
Title: Optical amplifier, amplification fibre co-doped with erbium and ytterbium
Inventor: PASQUALE FABRIZIO DI
IPC: H04B10/29
Filed: 1999-08-16
Abstract: n optical transmission system 100 intended to transmit an optical signal in a transmission wavelength band above 1570nm includes an optical amplifier  104 including an amplification fibre and a pump source for generating pump radiation.  The amplification fibre includes an optical fibre co-doped with erbium and ytterbium.  The concentration of erbium in the core of the amplification fibre is between 600ppm and 1000ppm.  The concentration  of ytterbium in the core is between 1000 and 20000 ppm.
Patent NZ-337667-A (NZ)
Title: Device for altering the course of a boat equipped with an automatic pilot with a magnetic compass
Inventor: BRUNO MARCEL
IPC: B63C9/00
Filed: 1998-02-18
Abstract: A device (50) for altering the course of a boat equipped with an automatic control system with magnetic compass (5), actuated on receiving an alarm signal (ba) comprises means for blocking the compass on a fictitious North.  The means for blocking the compass comprise two coils (B1, B2) arranged in the proximity of the compass along complementary axes, means (21, 22, 23, 24) for exciting each of the coils in accordance with a course signal (r1, r2, r3) or a signal of the boat list (bi), so as to preferably make the compass (5) turn counter-clockwise when the list is on starboard side and clockwise when the list is on portside, whatever the route followed by the boat.
Patent NZ-501118-A (NZ)
Title: Vascular adhesion protein-1 having amine oxidase activity
Inventor: SMITH DAVID JOHN
IPC: C12N9/06
Filed: 1998-05-22
Abstract: A method of oxidizing an amine such as benzylamine or methylamine comprises reacting the amine with a transmembrane form of a vascular adhesion protein-1 (VAP-1) polypeptide having amine oxidase activity.  The VAP-1 polypeptide can have the amino acid sequence SEQ ID No 2 or the amino acid sequence encoded by the VAP-1 nucleotide sequence SEQ ID NO 2. A method of inhibiting amine oxidase activity comprises adding an inhibitor such as semicarbazide, hydroxylamine, propargylamine, isoniazid, nialamide, hydrallazine or procarbazine to a sample possessing the amine oxidase activity.
Patent NZ-503136-A (NZ)
Title: Sulphated metal compounds as phosphate binders
Inventor: ROBERTS NORMAN BRYSON
IPC: C01B32/60
Filed: 1998-09-18
Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30 %, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30 % by weight of the total phosphate present, over a pH range from 2-8.
Patent NZ-505374-A (NZ)
Title: Isolated fragment of surface protein of N. meningitidis and compositions thereof for treating or diagnosing Meningococcal meningitis and septicemia
Inventor: PEAK IAN RICHARD ANSELM
IPC: A61P31/04
Filed: 1998-12-14
Abstract: An isolated surface polypeptide or fragment thereof, wherein the isolated polypeptide comprises amino acid residues 307-332 of Seq ID: 2 obtained from Neisseria meningitidis is described. The pharmaceutical compositions thereof are described to be useful in diagnosis, therapeutic and prophylactic vaccines related to the treatment of N. meningitidis related disorders.
Patent NZ-507670-A (NZ)
Title: Concentrate composition comprising plant treatment compound in acid form and a surfactant
Inventor: GILLESPIE JANE L
IPC: A01N25/04
Filed: 1999-04-23
Abstract: A concentrate composition for application to foliage of a plant to elicit a biological activity in the plant following dilution, dissolution or dispersion of the composition in water, the composition comprising: i) A plant treatment compound that is an acid having a solubility in deionized water at 25oC of less than 50 g/l, the plant treatment compound being present, predominantly in the acid form thereof, in an amount of 20% to 90% by weight, expressed as acid equivalent, of the composition; and ii) A surfactant of formula R-O-(CH2CH2O)n-H wherein R is a straight or branched chain aliphatic hydrocarbyl group having 24 to 60 carbon atoms and n is an integer having an average value of 5 to 100; The weight ratio of the surfactant to the plant treatment compound, expressed as acid equivalent, is 1: 2 to 1: 30. Also described is a method of killing or controlling unwanted vegetation comprising diluting in a suitable volume of water a herbicidally effective amount of a composition of Claim 3 to make a spray composition, and applying the spray composition by spraying the foliage of the unwanted vegetation.
Patent NZ-507811-A (NZ)
Title: Method for the collection and initial preparation of tissue samples for molecular genetic diagnosis
Inventor: BREM GOTTFRIED
IPC: C12Q1/6806
Filed: 1998-05-25
Abstract: A  device  and  a  method  for  taking  and  initially preparing tissue, blood or other samples with cells or  cell components  containing a core or DNA for  molecular  genetic tests.   The  device  comprises a  sample  container  and  a sample  collection  tool, the sample collection  tool  being inserted  in the sample container after the sample has  been obtained,  and  sealed  inside the  container.   The  sample container has a bottom and side walls and is closed  with  a penetrable  lid.   It  also includes means  for  fixing  the inserted  sample collection tool in an area of the container side  walls  distant  from  the bottom,  whereby  protection against  enzymes having a catabolic effect  on  the  DNA  is provided.   Once  inserted  in  the  sample  container,  the sample  collection tool is fixed in a stable manner  to  the means  for  fixing provided in the sample  container.   This has  the  effect  of dividing the sample container  into  at least  one  sample chamber delimited by the bottom  and  the side walls of the sample container and the front end of  the sample collection tool.
Patent NZ-508352-A (NZ)
Title: Hybrid polypeptides with a core therapeutic peptide further characterised with either amino and carboxy terminal linked enhancer or a carboxy terminal linked enhancer
Inventor: BARNEY SHAWN
IPC: A61P31/04
Filed: 1999-05-20
Abstract: A hybrid polypeptide comprising an enhancer peptide sequence linked to a core polypeptide, wherein the enhancer peptide sequence is 4 to 30 amino acid residues in length comprising: WXXWXXXI, WXXWXXX, WXXWXX, WXXWX, WXXW, WXXXWXWX, XXXWXWX, XXWXWX, XWXWX, WXWX, WXXXWXW, WXXXWX, WXXXW, IXXXWXXW, XXXWXXW, XXWXXW, XWXXW, XWXXXW, XWXWXXX, XWXWXX, XWXW, WXWXXXW or XWXXXW; in which amino acid residues are presented by the single-letter code and X is any amino acid, further wherein the hybrid polypeptide sequence does not consist of YTSLIHSLIEESQNQQEKNEQELLELDKWASLW, YTSLIHSLIEESQNQQEKNEQELLELDKWASLWN, YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW, YTSLIHSLIEESQNQQEKNEQELLEDKWASLWNW or YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF: said hybrid polypetide enhances the pharmocokinetic properties of the core polypeptide.
Patent NZ-512779-A (NZ)
Title: Method  of  pretreating waste water by inoculation  of micro organisms prior to receipt at sewage plants
Inventor: BELLAMY KENNETH MICHAEL
IPC: C02F3/30
Filed: 2001-07-04
Abstract: A  method  of  treating waste water  and  particularly sewerage.   The method involves treating the conduit  system making  up the sewerage network before it reaches a  typical sewerage  treatment  plant.  A key  feature  of  the  method involves   introducing   an  inoculum   (16)   of   selected microorganisms into a quiescent zone in the conduit  system. The  quiescent  zone  is  where the water  is  significantly slowed  in  it's  passage along the conduit system  and  may even  be temporarily stationary e.g. a pumping well (10)  or low  point  in  two  sections of pipe.  By  introducing  the inoculum,   a   competitive  culture  of  favorable   micro- organisms  is  incubated which is able to  out  compete  the undesirable  micro-organisms  and  lead  to  breakdown   and degradation of the sewerage in the conduit system before  it gets  down  to  the treatment pant. Further, by  suppressing the   undesirable  microorganisms,  damage  to  the  conduit system and problems with odorous gases are reduced.
Patent NZ-514549-A (NZ)
Title: Self-propelled irrigator
Inventor: KIRK JONATHAN CHARLES
IPC: A01G25/09
Filed: 2001-10-01
Abstract: A self-propelled irrigation system.  The system includes: a ground-engaging vehicle (100) propelled by a liquid pressure activated drive; a rotating boom (1) supported on the vehicle, the boom having at least one sprinkler (2) fixed thereto; a relatively flexible conduit (14) adapted to be fixed to a supply main for supplying pressurized liquid to the vehicle; and means (12) for restraining the travel of the vehicle along a closed path.
Patent NZ-523507-A (NZ)
Title: High throughput, possibly automated, process for transposition-mediated sequencing of target DNA fragments in which the amount of non-target DNA sequence is minimised
Inventor: AUGUST PAUL R
IPC: C12Q1/6869
Filed: 2001-07-05
Abstract: Described is an automated method of transposon-mediated multiplex sequencing of DNA fragments inserted into a vector. Particularity described is an increased efficiency in such automated methods, where the increased efficiency is obtained by screening out before sequencing those constructs in which the transposon inserted into the vector sequence. This prevents a waste of time and resources in performing reactions sequencing the vector instead of the DNA fragments of interest.
Patent NZ-524100-A (NZ)
Title: 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
Inventor: GRANT ELFRIDA R
IPC: A61K31/505
Filed: 2001-08-06
Abstract: A pharmaceutical composition comprising compound of formula I; the use of the compound in the manufacture of a medicament for the reduction of ischemic death in a cell population; and the use of the compound in the manufacture of a medicament for the reduction of neuronal cell death in response to a traumatic event.
Patent NZ-524421-A (NZ)
Title: Chemokine receptor binding heterocyclic compounds
Inventor: BRIDGER GARY
IPC: A61K31/4706
Filed: 2001-09-17
Abstract: Disclosed are compounds of formula (1), wherein: X is a monocyclic or fused bicyclic optionally substituted ring system containing at least one heteroatom, Z is H or a monocyclic or fused bicyclic optionally substituted ring system containing at least one heteroatom, Ar is an optionally substituted aromatic or heteroaromatic ring, each of L1, L2 and L3 is independently a bond, CO, SO2, or CH2, wherein at least one of L2 and L3 must comprise CO or SO2, and wherein L1 can also be alkylene wherein one or two C may optionally be replaced by N and which alkylene may itself optionally be substituted by a bridge alkylene, L2 and L3 may also be, independently SO2NH, CONH, SO2NHCH2 or CONHCH2, n is 0, 1 or 2, each R1 and R2 is independently H or straight or branched chain or cyclic alkyl which may be optionally substituted, and wherein R2 may be alkylene coupled to Y, Y comprises at least one aromatic or heteroaromatic or other heterocyclic substituted or unsubstituted ring directly couple to L3, and with the proviso that if X is pyridyl and L3 is a bond, Y cannot be 2-amino-phenyl. The compounds are used in the manufacture of medicaments for treating conditions modulated by the chemokine receptor CXC4 or CCR5.
Patent NZ-528970-A (NZ)
Title: Interactive learning and career management system
Inventor: PHILLIPS NIGEL JUDE PATRICK
IPC: G09B5/06
Filed: 2002-04-22
Abstract: A system for providing a user with information to enhance the user's learning and development comprises: a server means (6) connected to a communications network (8), the server means (6) having memory means (12), processing means (10), and data storage means (14);processing terminal means (3,4,5,7) connected to the communication network (8) for accessing the server means (6);wherein computer program means stored in the memory means (12) of the server means (6) searches information sources for the information, the information sources is linked to the communications network (8) and wherein the information is relevant to the user based on user profile data; the user profile data includes user psychometric profile data and user personal profile data and user electronic storage means for the user into which the information is forwarded for presentation to and accessible by the user.
Patent NZ-530262-A (NZ)
Title: Method of melt processing crosslinked thermoplastic material for recycling the material
Inventor: BOURLAND LARRY
IPC: C08J11/06
Filed: 2002-06-21
Abstract: A method of melt processing of crosslinked thermoplastic material in recycling plastic forming a mixture is disclosed comprising: (i) 100 weight parts of crosslinked thermoplastic resin having a given melt flow index of at most about 0.5 g/10 minutes; (ii) from about 0.1 to about 150 weight parts of polymeric resin having an weight-average molecular weight of at least about 2,000 and a melt flow index of at least about 10 times the given melt flow index of the crosslinked thermoplastic resin and melt flow index of at least about 4.5 g/10 minutes; and exposing the mixture to mechanical shearing energy to create a processed mixture having a melt flow index as disclosed in the specification.
Patent NZ-530669-A (NZ)
Title: Improvements in rotary moulding
Inventor: JONES RORY MACPHERSON
IPC: B29C41/04
Filed: 2004-01-15
Abstract: A method of rotary moulding whereby there is a provision for an air flow into the mould when the pressure differential from without and within the mould favours such an inflow and where there can be an outflow only when there is a pressure differential where the pressure within the mould is above a threshold pressure with respect to the pressure without the mould.
Patent NZ-531484-A (NZ)
Title: Use of 4-pyridylmethylphthalazines for cancer treatment
Inventor: DUGAN MARGARET HAN
IPC: A61K33/243
Filed: 2002-09-11
Abstract: Disclosed is a combination which comprises (a) a 4-pyridylmethyl-phthalazine antiangiogenic agent and (b) a platinum compound and an antineoplastic antimetabolite and, optionally, folinic acid, wherein the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt. Formulated as a unit dosage form in the range of 500 mg/day to 4000 mg/day these 4-pyridylmethyl-pthalazine derivatives are used in the treatment of a proliferative disease such as a solid tumour disease.
Patent NZ-532694-A (NZ)
Title: High density non-toxic composites comprising tungsten, another metal and polymer powder
Inventor: ELLIOTT KENNETH H
IPC: B22F1/00
Filed: 2002-10-15
Abstract: Tungsten/polymer composites comprising tungsten powder, another metal powder having a high packing density, and an organic comprising a thermoplastic elastomer or a blend of thermoplastic elastomer are disclosed. Preferably, the other metal is a stainless steel, iron, ferrous alloy, or bronze. The organic binder remains part of the finished article after processing and becomes part of he matrix for holding the composite together. Such composites are useful as lead replacements, particularly in the manufacture of a bullet shot.